Zealand Pharma A/S
ZLDPF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $63 | $343 | $104 | $293 |
| % Growth | -81.7% | 229.6% | -64.5% | – |
| Cost of Goods Sold | $8 | $19 | $31 | $119 |
| Gross Profit | $55 | $324 | $73 | $174 |
| % Margin | 87.4% | 94.4% | 70.5% | 59.4% |
| R&D Expenses | $920 | $685 | $614 | $588 |
| G&A Expenses | $161 | $74 | $274 | $261 |
| SG&A Expenses | $229 | $90 | $307 | $636 |
| Sales & Mktg Exp. | $69 | $16 | $32 | $375 |
| Other Operating Expenses | $178 | $121 | $0 | -$1 |
| Operating Expenses | $1,327 | $896 | $921 | $1,224 |
| Operating Income | -$1,272 | -$572 | -$817 | -$1,050 |
| % Margin | -2,029.3% | -166.9% | -785.3% | -359% |
| Other Income/Exp. Net | $189 | -$137 | -$135 | $286 |
| Pre-Tax Income | -$1,083 | -$709 | -$972 | -$764 |
| Tax Expense | -$5 | -$5 | -$6 | -$9 |
| Net Income | -$1,079 | -$704 | -$966 | -$1,018 |
| % Margin | -1,720.9% | -205.3% | -928.6% | -348% |
| EPS | -16.24 | -12.44 | -20.9 | -23.75 |
| % Growth | -30.5% | 40.5% | 12% | – |
| EPS Diluted | -16.24 | -12.44 | -20.9 | -23.75 |
| Weighted Avg Shares Out | 66 | 57 | 46 | 43 |
| Weighted Avg Shares Out Dil | 66 | 57 | 46 | 43 |
| Supplemental Information | – | – | – | – |
| Interest Income | $170 | $45 | $7 | $0 |
| Interest Expense | $34 | $25 | $56 | $4 |
| Depreciation & Amortization | $26 | $25 | $31 | $25 |
| EBITDA | -$1,024 | -$658 | -$665 | -$712 |
| % Margin | -1,632.7% | -191.9% | -639.8% | -243.3% |